Butrans FDA Approval History
FDA Approved: Yes (First approved June 30, 2010)
Brand name: Butrans
Generic name: buprenorphine
Dosage form: Transdermal System
Company: Purdue Pharma L.P.
Treatment for: Pain
Butrans (buprenorphine) is a transdermal opioid analgesic for the management of moderate to severe chronic pain in patients requiring continuous treatment for an extended period of time.
Development timeline for Butrans
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.